JP2009536021A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536021A5
JP2009536021A5 JP2009504310A JP2009504310A JP2009536021A5 JP 2009536021 A5 JP2009536021 A5 JP 2009536021A5 JP 2009504310 A JP2009504310 A JP 2009504310A JP 2009504310 A JP2009504310 A JP 2009504310A JP 2009536021 A5 JP2009536021 A5 JP 2009536021A5
Authority
JP
Japan
Prior art keywords
sample
ratio
leukocytes
mrna
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504310A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009536021A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/008559 external-priority patent/WO2007117589A2/en
Publication of JP2009536021A publication Critical patent/JP2009536021A/ja
Publication of JP2009536021A5 publication Critical patent/JP2009536021A5/ja
Pending legal-status Critical Current

Links

JP2009504310A 2006-04-07 2007-04-05 関節リウマチの患者の末梢血白血球におけるFC受容体媒介性腫瘍壊死因子スーパーファミリ及びケモカインのmRNA発現の増大 Pending JP2009536021A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79051106P 2006-04-07 2006-04-07
PCT/US2007/008559 WO2007117589A2 (en) 2006-04-07 2007-04-05 Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis

Publications (2)

Publication Number Publication Date
JP2009536021A JP2009536021A (ja) 2009-10-08
JP2009536021A5 true JP2009536021A5 (enExample) 2010-01-07

Family

ID=38581639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504310A Pending JP2009536021A (ja) 2006-04-07 2007-04-05 関節リウマチの患者の末梢血白血球におけるFC受容体媒介性腫瘍壊死因子スーパーファミリ及びケモカインのmRNA発現の増大

Country Status (3)

Country Link
US (1) US20090311684A1 (enExample)
JP (1) JP2009536021A (enExample)
WO (1) WO2007117589A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776471B9 (en) * 2004-05-25 2013-12-18 Hitachi Chemical Company, Ltd. Method of measuring cancer susceptibility
JP4772055B2 (ja) * 2004-10-20 2011-09-14 日立化成工業株式会社 mRNAの定量により薬剤の投与を選定する方法
JP4945554B2 (ja) * 2005-04-28 2012-06-06 ヒタチ ケミカル リサーチ センター インコーポレイテッド 食物サプリメントに対する個体変動評価のモデルとしての全血におけるexvivo遺伝子発現
WO2009070442A2 (en) 2007-11-14 2009-06-04 Hitachi Chemical Co. Ltd. Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease
CN115851887A (zh) * 2022-08-08 2023-03-28 山西中医药大学 一种类风湿关节炎中趋化因子表达及定位的检测方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925572A (en) * 1987-10-20 1990-05-15 Pall Corporation Device and method for depletion of the leukocyte content of blood and blood components
US4880548A (en) * 1988-02-17 1989-11-14 Pall Corporation Device and method for separating leucocytes from platelet concentrate
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5491063A (en) * 1994-09-01 1996-02-13 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
PT938320E (pt) * 1996-03-26 2010-09-22 Michael S Kopreski Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
US7514232B2 (en) * 1996-12-06 2009-04-07 Becton, Dickinson And Company Method for detecting T cell response to specific antigens in whole blood
US20020006613A1 (en) * 1998-01-20 2002-01-17 Shyjan Andrew W. Methods and compositions for the identification and assessment of cancer therapies
US20020048566A1 (en) * 2000-09-14 2002-04-25 El-Deiry Wafik S. Modulation of cellular apoptosis and methods for treating cancer
US7374881B2 (en) * 2000-10-31 2008-05-20 Hitachi Chemical Research Center, Inc. Method for collecting and using nuclear mRNA
US6993384B2 (en) * 2001-12-04 2006-01-31 Advanced Bionics Corporation Apparatus and method for determining the relative position and orientation of neurostimulation leads
US7745180B2 (en) * 2002-04-24 2010-06-29 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
EP1776471B9 (en) * 2004-05-25 2013-12-18 Hitachi Chemical Company, Ltd. Method of measuring cancer susceptibility
JP4945554B2 (ja) * 2005-04-28 2012-06-06 ヒタチ ケミカル リサーチ センター インコーポレイテッド 食物サプリメントに対する個体変動評価のモデルとしての全血におけるexvivo遺伝子発現
US7935482B2 (en) * 2005-09-27 2011-05-03 Source Precision Medicine, Inc. Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis

Similar Documents

Publication Publication Date Title
Lynch et al. Clinical improvement of asthma after anthelminthic treatment in a tropical situation
Laube et al. Frailty in advanced liver disease
Nilsson et al. The metabolic syndrome–What is it and how should it be managed?
Feary et al. Experimental hookworm infection: a randomized placebo‐controlled trial in asthma
Kahle et al. Interaction effects of temperature and ozone on lung function and markers of systemic inflammation, coagulation, and fibrinolysis: a crossover study of healthy young volunteers
Blunt et al. Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness
Palone et al. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease
Sood et al. Adult-onset asthma becomes the dominant phenotype among women by age 40 years. The longitudinal CARDIA study
Herbert et al. Depression and immunity: a meta-analytic review.
Zhang et al. Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: a multicentre study
Nair et al. How to diagnose and phenotype asthma
Santos et al. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy
JP2009536021A5 (enExample)
Dahlén et al. Basophil allergen threshold sensitivity, CD‐sens, is a measure of allergen sensitivity in asthma
İlçin et al. Cross-cultural adaptation and validation of the Turkish version of the pain catastrophizing scale among patients with ankylosing spondylitis
Yamashita et al. Features of trunk muscle wasting during acute care and physical function recovery with aortic disease
Luijk et al. Effect of an inhaled adenosine A2A agonist on the allergen‐induced late asthmatic response
Oshitani et al. Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment
Janczura et al. Potential roles of psychological and oxidative stress in insulin resistance: a cohort-based study
Rose et al. Partial body cryotherapy exposure drives acute redistribution of circulating lymphocytes: preliminary findings
Barton et al. Benign migratory glossitis and allergy
Narenpitak et al. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand
Wang et al. New animal model of chronic gout reproduces pathological features of the disease in humans
Leung et al. A randomized, single‐blind and crossover study of an amino acid‐based milk formula in treating young children with atopic dermatitis
Yariktas et al. Asymptomatic food hypersensitivity prevalence in patients with eczematous external otitis